J.I. Roodnat

J.I. Roodnat is a Researcher in the Department of Internal Medicine at Erasmus MC, a leading medical university center in the Netherlands. The research focuses on kidney transplantation, graft survival, and metabolic complications in renal disease, with a strong emphasis on clinical and translational outcomes.

Research Interests: Roodnat's work centers on improving outcomes in kidney transplantation, particularly through understanding the impact of oxalic acid, residual diuresis, and HLA antibody profiles. Research spans immunosuppressive strategies, desensitization protocols, and long-term function in both recipients and living donors. Key topics include graft failure prediction, therapeutic drug monitoring, and metabolic nephrology.

The recent publications indicate a strong trend in clinical and metabolic research in transplantation, particularly focusing on modifiable factors affecting graft survival and donor safety. Studies integrate biochemical markers, clinical parameters, and immunological profiling to optimize transplant outcomes.

Collaborations and Supervision: Roodnat actively collaborates with multidisciplinary teams at Erasmus MC, including nephrologists, immunologists, and clinical chemists. The researcher has contributed to supervised academic work, including doctoral theses and peer-reviewed publications, reflecting a role in mentoring and academic guidance. While no formal grants are listed, the volume and quality of research suggest involvement in funded projects within the transplant program.

Laboratory and Research Group: Work is conducted within the transplant research unit at Erasmus MC, which specializes in clinical transplantation studies, biomarker discovery, and immunological monitoring. The team is part of a larger network focused on improving solid organ transplantation outcomes through evidence-based strategies.